The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The application of electrosprayed minocycline‐loaded PLGA microparticles for the treatment of glioblastoma
Abstract
The survival of patients with glioblastoma multiforme (GBM), the most common and invasive form of malignant brain tumors, remains poor despite advances in current treatment methods including surgery, radiotherapy, and chemotherapy. Minocycline is a semi‐synthetic tetracycline derivative that has been widely used as an antibiotic and more recently, it has been utilized as an antiangiogenic factor to inhibit tumorigenesis. The objective of this study was to investigate the utilization of electrospraying process to fabricate minocycline‐loaded poly(lactic‐co‐glycolic acid) (PLGA) microparticles with high drug loading and loading efficiency and to evaluate their ability to induce cell toxicity in human glioblastoma (i.e., U87‐MG) cells. The results from this study demonstrated that solvent mixture of dicholoromethane (DCM) and methanol is the optimal solvent combination for minocycline and larger amount of methanol (i.e., 70:30) resulted in a higher drug loading. All three solvent ratios of DCM:methanol tested produced microparticles that were both spherical and smooth, all in the micron size range. The electrosprayed microparticles were able to elicit a cytotoxic response in U87‐MG glioblastoma cells at a lower concentration of drug compared to the free drug. This work provides proof of concept to the hypothesis that electrosprayed minocycline‐loaded PLGA microparticles can be a promising agent for the treatment of GBM and could have potential application for cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
MAO, S., XU, J., CAI, C., GERMERSHAUS, O., SCHAPER, A., & KISSEL, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.036 · Cited by 283
Zhang, T., Qiu, Y., Song, J., Zhou, P., Liao, H., Cheng, Y., & Wu, X. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1902020 · Cited by 36
Minocycline inhibits angiogenesis in vitro through the translational suppression of HIF-1α
Jung, H.-J., Seo, I., Jha, B. K., Suh, S.-I., Suh, M.-H., & Baek, W.-K. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.023 · Cited by 27
Research works printed but not linked: 48
- 10.1016/j.jconrel.2009.09.032 · DOI
- 10.1002/jbm.b.31085 · DOI · Paper page
- 10.3389/fncom.2020.00061 · DOI
- 10.1007/s40005-019-00453-z · DOI · Paper page
- 10.1016/j.ejpb.2014.03.008 · DOI
- 10.3171/2013.11.JNS13556 · DOI
- 10.1093/neuonc/now086 · DOI
- 10.1002/jbm.a.35657 · DOI
- 10.1007/s11095-007-9457-3 · doi:10.1007/s11095-007-9457-3
- 10.1023/A:1025695423097 · DOI
- 10.1016/j.ijpharm.2004.04.013 · DOI · Paper page
- 10.1016/S1875-5364(18)30007-4 · DOI
- 10.1016/j.ijpharm.2016.01.011 · DOI
- 10.1016/j.jaerosci.2008.02.004 · DOI · Paper page
- 10.1038/am.2013.26 · DOI
- 10.1002/bit.21301 · DOI · Paper page
- 10.1002/jbm.1261 · DOI
- 10.1002/jbm.a.30654 · DOI · Paper page
- 10.1016/S0168-3659(96)01477-0 · DOI
- 10.1016/j.ejps.2006.08.005 · DOI · Paper page
- 10.1016/j.ijpharm.2008.07.018 · DOI · Paper page
- 10.1093/neuonc/not073 · DOI
- 10.4161/auto.7.2.14043 · DOI
- 10.3390/cancers4010218 · DOI
- Manome Y., 2006, Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet, Anticancer Research, 26, 3317
- 10.1200/JCO.2013.51.8886 · DOI · Paper page
- 10.1016/0142-9612(93)90151-Q · DOI · Paper page
- 10.1016/j.ab.2020.113937 · DOI
- 10.1016/j.xphs.2016.04.024 · DOI · Paper page
- 10.1093/neuonc/noab200 · DOI · Paper page
- 10.1016/j.ijpharm.2016.01.020 · DOI · Paper page
- 10.1002/jbm.b.34324 · DOI
- 10.3390/ma3063537 · DOI · Paper page
- 10.1039/d1nr02065j · DOI · Paper page
- 10.1016/j.biomaterials.2010.01.112 · DOI
- 10.4161/biom.24281 · DOI · Paper page
- 10.1557/jmr.2020.24 · doi:10.1557/jmr.2020.24
- 10.1002/jps.24695 · DOI
- 10.3171/jns.1995.82.4.0635 · DOI
- 10.1215/S1522-8517-02-00023-6 · doi:10.1215/s1522-8517-02-00023-6
- 10.1016/j.biomaterials.2006.01.034 · DOI · Paper page
- 10.1038/jcbfm.2012.48 · DOI
- 10.1080/10717544.2019.1568620 · DOI · Paper page
- 10.1007/BF02980037 · DOI · Paper page
- 10.1016/S0099-5428(08)60348-2 · doi:10.1016/s0099-5428(08)60348-2
- 10.3390/ijms13011109 · doi:10.3390/ijms13011109
- 10.1016/j.ijpharm.2006.08.027 · DOI
- 10.3390/app9030402 · DOI
Metadata
- Authors
- Arriaga, M. A., Amieva, J. A., Quintanilla, J., Jimenez, A., Ledezma, J., Lopez, S., Martirosyan, K. S., & Chew, S. A.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2023-08-22
- Volume
- 120
- Issue
- 11
- Pages
- 3409-3422
- ISSN
- 0006-3592
- 1097-0290
- Cited by
- 2
- References
- 5
- Language
- en
- Licence
- Funders
- National Institute of General Medical Sciences
- National Science Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.